
Ajax Therapeutics
Developer of targeted therapy drugs designed for the treatment of hematologic cancers. The company leverages advances in molecular genetics and biology to develop new classes of therapies that are hig...
Valuation
$192.5M
Latest known
Share Price
N/A
Total Raised
$143M
Last Round
N/A